122 results on '"Paik S.W."'
Search Results
2. Nonsurgical treatment of abdominal or pelvic abscess in consecutive patients with Crohn's disease
3. Non-surgical management of microperforation induced by EMR of the stomach
4. The role of follow-up endoscopy after total gastrectomy for gastric cancer
5. Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)
6. Increased risk of peristomal wound infection after percutaneous endoscopic gastrostomy in patients with diabetes mellitus
7. Is lamivudine with 1-week hblg as effective as long-term high-dose hblg in hbv prophylaxis after liver transplantation?
8. Role of autonomic dysfunction in patients with functional dyspepsia
9. CA209-9DX: Phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
10. Real-world data on nivolumab treatment in Asian patients with advanced hepatocellular carcinoma
11. Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial
12. Comparision of long-term outcome for single small hepatocellular carcinoma between different treatment modalities by size and tumor marker
13. Characteristics and outcomes of patients with late presentation of hepatitis B among newly-diagnosed hepatocellular carcinoma: A national cohort study 2002–2013
14. Spatially and temporally resolved temperature measurements for slow evaporating sessile drops heated by microfabricated heater array
15. A phase III trial of muparfostat (PI-88) as adjuvant therapy in patients with hepatitis virus related hepatocellular carcinoma (HV-HCC) after resection
16. Safety of glecaprevir/pibrentasvir in adults with chronic genotype 1–6 hepatitis C virus infection: an integrated analysis
17. Albumin-Bilirubin grade based novel risk prediction model for patients with hepatocellular carcinoma undergoing chemoembolization
18. Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin in Asian patients with genotype 1b chronic hepatitis C virus infection and compensated cirrhosis: ONYX-II post-treatment week 24 results
19. Nonalcoholic fatty liver disease and development of chronic kidney disease: a retrospective cohort study
20. Effectiveness of Peginterferon Alfa-2a Therapy in HBeAg-Positive and HBeAg-Negative Patients with Chronic Hepatitis B: Final Results 3 Years Post-Treatment of the Prospective, Global, Observational S-Collate Study
21. Primary Prophylaxis For Variceal Bleeding Should be done for Patients with Hepatocellular Carcinoma
22. Outcomes in patients with hepatopulmonary syndrome undergoing liver transplantation
23. Can we expand the Milan criteria for hepatocellular carcinoma in living donor liver transplantation?
24. Factors affecting graft survival after living donor liver transplantation
25. 209TiP - CA209-9DX: Phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
26. 783TiP - CA209-9DX: phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
27. 699P - Real-world data on nivolumab treatment in Asian patients with advanced hepatocellular carcinoma
28. THU-165 - Comparision of long-term outcome for single small hepatocellular carcinoma between different treatment modalities by size and tumor marker
29. THU-092 - Characteristics and outcomes of patients with late presentation of hepatitis B among newly-diagnosed hepatocellular carcinoma: A national cohort study 2002–2013
30. Safety of the donor with right hepatic lobectomy in the living donor liver transplantation
31. P1335 : A randomized, controlled phase III trial of sorafenib with or without conventional transarterial chemoembolization in patients with advanced hepatocellular carcinoma (STAH)
32. 624PD - A phase III trial of muparfostat (PI-88) as adjuvant therapy in patients with hepatitis virus related hepatocellular carcinoma (HV-HCC) after resection
33. Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine
34. The Analysis of the Current Situation in Design Change of Temporary Structures
35. P963 SINGLE HCC ≤3cm IN LEFT LATERAL SEGMENT: LIVER RESECTION OR RADIOFREQUENCY ABLATION?
36. P1118 NO EFFECT OF FALDAPREVIR ON RENAL FUNCTION IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: POOLED DATA FROM TWO PHASE III TRIALS
37. P549 CHRONIC HEPATITIS B PATIENTS TREATED WITH ORAL ANTIVIRAL THERAPY HAVE STILL HIGHER RISK FOR HEPATOCELLULAR CARCINOMA COMPARED TO INACTIVE STAGE PATIENTS
38. Expanded Criteria for Liver Transplantation in Patients with Hepatocellular Carcinoma
39. A Study on the Design Change of High-Risk Temporary Structures
40. Prophylaxis against hepatitis B recurrence following liver transplantation in HBs Ag(+) patients
41. SAT-081 - Primary Prophylaxis For Variceal Bleeding Should be done for Patients with Hepatocellular Carcinoma
42. FRI-137 - Effectiveness of Peginterferon Alfa-2a Therapy in HBeAg-Positive and HBeAg-Negative Patients with Chronic Hepatitis B: Final Results 3 Years Post-Treatment of the Prospective, Global, Observational S-Collate Study
43. 41 S-Collate COHORT ‘REAL-LIFE’ STUDY: EFFICACY AND SAFETY OF PEGINTERFERON alfa-2a (40KD) IN 1233 PATIENTS WITH CHRONIC HEPATITIS B ACCORDING TO ASIAN AND CAUCASIAN RACE
44. 749 RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEPATITIS B VIRUS PRE-S MUTATION: LONG-TERM FOLLOW-UP DATA
45. 1022 CLINICAL COURSE OF SUB-CENTIMETER-SIZED NODULES DETECTED DURING SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA IN PATIENTS AT RISK
46. 750 SCREENING FAILURE RATE DURING HEPATOCELLULAR CARCINOMA SURVEILLANCE; A ROLE OF ALTERNATING SURVEILLANCE WITH ULTRASOUND AND COMPUTED TOMOGRAPHY
47. 1320 SERUM OSTEOCALCIN LEVEL IS CLOSELY ASSOCIATED WITH THE PRESENCE, NEW DEVELOPMENT AND REGRESSION OF ULTRASONOGRAPHICALLY DETECTED FATTY LIVER IN AGED WOMEN
48. Effectiveness of Locoregional Therapy Before Living Donor Liver Transplantation in Patients With Hepatocellular Carcinoma Who Meet the Milan Criteria
49. 158 MORTALITY AFTER SURGERY IN PATIENTS WITH LIVER CIRRHOSIS: COMPARISON BETWEEN CTP, MELD AND MELDNA SCORE
50. 22 A COMPARISON OF 24 WEEKS AND 48 WEEKS TREATMENT EFFICACY BETWEEN CLEVUDINE AND ENTECAVIR THERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.